Key Details
Price
$23.37Annual ROE
-5.24%Beta
2.89Events Calendar
Next earnings date:
Feb 25, 2025Recent quarterly earnings:
Nov 5, 2024Recent annual earnings:
Feb 29, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Sep 23, 2024Analyst ratings
Recent major analysts updates
Market Data
Price
Market cap
Technical
Dividend
Profitability
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Liquidity
Leverage
Risk & Stability
Balance Sheet
Assets
Equity
Liabilities
Debt
Expenses
Cash Flow
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
MultiPlan (MPLN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
NEW YORK--(BUSINESS WIRE)---- $MPLN #MPLN--MultiPlan Corporation (“MultiPlan” or the “Company”) (NYSE: MPLN), a leading provider of technology and data solutions that improve affordability, quality and transparency in healthcare, today announced an agreement with J2 Health, a cloud-based software solution that optimizes provider network performance. This strategic agreement will support MultiPlan's network optimization strategy, providing tailored solutions and resource efficiency that ultimately reduces healt.
NEW YORK--(BUSINESS WIRE)---- $MPLN #MPLN--MultiPlan Corporation (NYSE: MPLN) (“MultiPlan” or the “Company”), a leading provider of technology and data solutions focused on cost management, improving quality and transparency in healthcare, today announced a comprehensive refinancing to extend the maturities of its entire debt capital structure. MultiPlan has entered into an agreement (the “Transaction Support Agreement”) with certain ad hoc groups of noteholders and lenders collectively beneficially owning app.
MultiPlan Corporation (NYSE:MPLN ) Q3 2024 Earnings Conference Call November 5, 2024 8:30 AM ET Company Participants Shawna Gasik - AVP, IR Travis Dalton - CEO Doug Garis - CFO Conference Call Participants Joshua Raskin - Nephron Research Daniel Grosslight - Citigroup Jessica Tassan - Piper Sandler Madison Aron - JPMorgan Operator Hello and welcome to the MultiPlan Corporation Third Quarter 2024 Earnings Call. My name is Harry and I will be your operator today.
MultiPlan Corporation (MPLN) came out with a quarterly loss of $1.85 per share versus the Zacks Consensus Estimate of a loss of $2.37. This compares to loss of $2.40 per share a year ago.
NEW YORK--(BUSINESS WIRE)--MultiPlan Corporation (“MultiPlan” or the “Company”) (NYSE: MPLN), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare industry, today reported financial results for the third quarter ended September 30, 2024 and updated its full-year 2024 guidance. CEO Travis Dalton said, “During the third quarter, we experienced growth in volumes of billed charges and identified.
NEW YORK--(BUSINESS WIRE)---- $MPLN #MPLN--MultiPlan Corporation (NYSE:MPLN), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare industry, is accepting applications for its Rural Health Grant now through December 15, 2024 from rural healthcare providers in the U.S. The grants provide financial resources to introduce or expand services, education, screenings and other programs aimed at improving the health.
NEW YORK--(BUSINESS WIRE)---- $MPLN #MPLN--MultiPlan Corporation (“MultiPlan” or the “Company”) (NYSE: MPLN), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare industry, today announced a new addition to its executive leadership team to support the next phase of the Company's strategic growth. Tiffani Misencik has been appointed Chief Growth Officer. In this newly created role, Misencik will oversee Multi.
MultiPlan (MPLN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
MPLN and NRHA team up to empower rural healthcare providers with innovative technology and data-driven solutions, improving access, quality and affordability.
FAQ
- What is the ticker symbol for MultiPlan?
- Does MultiPlan pay dividends?
- What sector is MultiPlan in?
- What industry is MultiPlan in?
- What country is MultiPlan based in?
- When did MultiPlan go public?
- Is MultiPlan in the S&P 500?
- Is MultiPlan in the NASDAQ 100?
- Is MultiPlan in the Dow Jones?
- When was MultiPlan's last earnings report?
- When does MultiPlan report earnings?
- Should I buy MultiPlan stock now?